SEC Tracker
Get the app

Hepion Pharmaceuticals HEPA

Hepion Pharmaceuticals: signs a material agreement, takes on a new financial obligation and 4 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
Exhibit 10.4
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Hepion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. China Foods Holdings CFOO public float $864K, Jun 30, 2025
  2. Mosaic ImmunoEngineering CPMV public float $856K, Jun 30, 2025
  3. Twinlab Consolidated Holdings TLCC public float $1M, Jun 30, 2025
  4. Regen BioPharma RGBP public float $1M, Mar 31, 2025, over 18 months old
  5. Nutra Pharma NPHC public float $703K, Jun 30, 2025